| Literature DB >> 35589845 |
Maria Filippa Addis1, Elisa Margherita Maffioli2,3, Martina Penati2, Mariangela Albertini2, Valerio Bronzo2, Renata Piccinini2, Francesco Tangorra2, Gabriella Tedeschi2,3,4, Giovanna Cappelli5, Gabriele Di Vuolo5, Domenico Vecchio5, Esterina De Carlo5, Fabrizio Ceciliani2.
Abstract
Mastitis by non-aureus staphylococci (NAS) is a significant issue in dairy buffalo farming. In a herd with subclinical NAS mastitis, we identified Staphylococcus microti as the predominant species. To assess milk protein integrity and investigate potential disease markers, we characterized 12 NAS-positive and 12 healthy quarter milk samples by shotgun peptidomics combining peptide enrichment and high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS). We observed significant changes in the milk peptidome. Out of 789 total peptides identified in each group, 49 and 44 were unique or increased in NAS-positive and healthy milk, respectively. In NAS-positive milk, the differential peptides belonged mainly to caseins, followed by milk fat globule membrane proteins (MFGMP) and by the immune defense/antimicrobial proteins osteopontin, lactoperoxidase, and serum amyloid A. In healthy milk, these belonged mainly to MFGMP, followed by caseins. In terms of abundance, peptides from MFGMP and immune defense protein were higher in NAS-positive milk, while peptides from caseins were higher in healthy milk. These findings highlight the impact of NAS on buffalo milk quality and mammary gland health, even when clinical signs are not evident, and underscore the need for clarifying the epidemiology and relevance of the different NAS species in this dairy ruminant.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35589845 PMCID: PMC9120474 DOI: 10.1038/s41598-022-12297-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Somatic cell count (SCC) and bacterial species identified in the quarter milk samples subjected to peptidomic analysis. The last column reports the sample classification according to SCC value and presence of NAS. Complete data are reported in Supplementary Table 1.
| N | SCC1 | NAS2 species | CFU/mL3 | Score4 | Other bacteria | CFU/mL3 | Score4 | Sample group |
|---|---|---|---|---|---|---|---|---|
| 1 | 147,000 | 4000 | 1.95 | NAS-positive | ||||
| 2 | 290,000 | 1000 | 2.07 | NAS-positive | ||||
| 3 | 247,000 | 2000 | 1.93 | NAS-positive | ||||
| 4 | 246,000 | 1000 | 2.09 | NAS-positive | ||||
| 5 | 242,000 | 500 | 2.04 | 500 | 2.03 | NAS-positive | ||
| 6 | 233,000 | 1000 | 2.12 | NAS-positive | ||||
| 7 | 211,000 | 500 | 2.17 | NAS-positive | ||||
| 8 | 156,000 | 500 | 2.16 | NAS-positive | ||||
| 9 | 457,000 | 2000 | 2.13 | NAS-positive | ||||
| 10 | 413,000 | 2000 | 2.1 | 2000 | 2.29 | NAS-positive | ||
| 11 | 190,000 | 2000 | 2.27 | 2000 | 2.03 | NAS-positive | ||
| 12 | 335,000 | 2000 | 2.06 | NAS-positive | ||||
| 13 | 30,000 | Culture-negative | Healthy | |||||
| 14 | 21,000 | Culture-negative | Healthy | |||||
| 15 | 20,000 | Culture-negative | Healthy | |||||
| 16 | 50,000 | Culture-negative | Healthy | |||||
| 17 | 34,000 | Culture-negative | Healthy | |||||
| 18 | 24,000 | Culture-negative | Healthy | |||||
| 19 | 51,000 | Culture-negative | Healthy | |||||
| 20 | 48,000 | Culture-negative | Healthy | |||||
| 21 | 36,000 | Culture-negative | Healthy | |||||
| 22 | 73,000 | Culture-negative | Healthy | |||||
| 23 | 54,000 | Culture-negative | Healthy | |||||
| 24 | 27,000 | Culture-negative | Healthy |
1Somatic cell count in cells/mL of milk. 2Non-aureus staphylococci. 3Colony-forming units per mL of milk. 4Log score of the species identification by MALDI-TOF-MS.
Figure 1Shotgun label-free quantitative peptidomic analysis. (A) Overview of the protocols applied for the analysis of peptides in NAS-positive and healthy milk samples (B) Venn diagram of all the peptides identified in milk samples from healthy and NAS-positive buffaloes. Peptides were considered differentially abundant if they were present only in NAS-positiver or Control milk or showed significant Welch t test difference (cut-off at 1% permutation-based False Discovery Rate).
Total and unique peptides identified in the two sample groups by LC–MS/MS and differential analysis. Complete data are reported in Supplementary Table 2.
| Sample group | No. of total peptides | No. of unique and differential* peptides |
|---|---|---|
| NAS-positive | 789 | 44 + 5* |
| Healthy | 789 | 44 |
*Increased in the sample group based on the Welch t test with FDR ≤ 0.01.
Unique and significantly differential* peptides found in NAS-positive and healthy milk with the respective originating protein and its location/function according to the UniProtKB protein knowledge base or referenced literature sources, listed according to the originating protein and to the number of peptides derived from that protein.
| Originating protein | Location/function | |
|---|---|---|
| IPNSLPQNIPPLTQTPVVVPPFLQPEIMGVSKVKEAMAPKHKEMPFPK | Casein beta | Casein micelle |
| IPNSLPQNIPPLTQTPVVVPPFLQPEIMGVSKVKEAMAPK | ||
| EELNVPGEIVESLSSSEESITHINKK | ||
| EKFQSEEQQQMEDELQDK | ||
| LTQTPVVVPPFLQPEIMGVSKVKEAMAPKHK | ||
| LLYQEPVLGPVRGPFPI | ||
| FLLYQEPVLGPVRGPFP | ||
| VVPPFLQPEIMGVSKVKEAMAPKHK | ||
| AVPYPQRDMPIQAFLLYQEPVLGPVRGPFPII | ||
| LSLSQSKVLPVPQK | ||
| FLLYQEPVLGPVRGPFPI | ||
| APKHKEMPFPK | ||
| TQTPVVVPPFLQPEIMGVSKVKEAMAPKH | ||
| AMAPKHKEMPFPK | ||
| VVPPFLQPEIMGVSKVKEAMAPK* | ||
| FAWPQYLKTVYQYQKAMKPWTQPK | Casein alpha S2 | Casein micelle |
| NAVPITPTLNREQLSTSEENSKKTVDMESTEVFTK | ||
| DMESTEVFTK | ||
| EQLSTSEENSKKTVDMESTEVITK | ||
| SSEESIISQETYK | ||
| TVYQYQKAMKPWTQPKTNVIPYVRY | ||
| NAVPITPTLNREQLSTSEENSKKT* | ||
| MADEAESLEDLGFKGAHTTQKGHAKARP | Casein alpha S1 | Casein micelle |
| RPKQPIKHQGLPQGVLNENLLRFFVAPFPEVFGKEKV | ||
| KQPIKHQGLPQGVLNENLLRFFVAPFPEVFGK | ||
| FFVAPFPEVFGKEKV | ||
| FVAPFPEVFGKEKV* | ||
| VAPFPEVFGKEKV* | ||
| LPLTKDELEKEAKKVEGFDMVQKPSYYVR | Perilipin 2 | MFG membrane[ |
| STITGVVDRTKGAVTGSVEK | ||
| INTVLGSRVMQ | ||
| RQPQNQNPKLPLSILKEKHL | Glycosylation-dependent cell adhesion molecule 1 | MFG membrane[ |
| SSRQPQNQNPKLPLSILKEKHLRN | ||
| ILNEPEDETHLEAQPTDASAQFIRNLQISNEDLSK | ||
| LPVKPTSSGSSEEKQLNNKYPDAVATWLKPDPSQK | Osteopontin | Immune defense[ |
| PTDIPTIAVFTPFIPTESTNDGRGDSVAYGLKSRSKKF | ||
| RSNVQSPDATEEDFTSHIESEEMHDAPK | ||
| VAPEEHPVLLTEAPLNPK | Actin beta | Cytosol |
| EITALAPSTMK | ||
| VSPAVFVSREGREQE | Butyrophilin subfamily 1 member A1 | MFG membrane[ |
| IVDYYEPR | CD109 molecule | Plasma membrane |
| NVQTEIVNKHNDLRRGVSPPPRNML | Cysteine-rich secretory protein 3 | Secreted |
| DVEKDEKLIRL | DEAD-box helicase 5 | Nucleus/cytosol |
| NRHGSKASADESLALGKPGKEPR | Fibroblast growth factor-binding protein 1 | Plasma membrane |
| PARVLDLGPITR | Pancreatic secretory granule membrane major glycoprotein GP2 | MFG membrane[ |
| KTTLSSEAPTTQQLSEYFKHAKGQT | Lactoperoxidase | Immune defense |
| APAGAAIQSRAGEIQ* | Polymeric immunoglobulin receptor | MFG membrane[ |
| NPLFEKRPKNF | Ribosomal protein L7a | Cytosol |
| VISNARETIQGITDPLLKGMTRDQVREDSKADQFANEWGR | Serum amyloid A3 protein | Immune defense[ |
| DVPSERYLGYLEQLLR | Casein alpha S1 | Casein micelle |
| KKYNVPQLEIVPNLAEEQLHSM | ||
| QLEIVPNLAEEQLHSM | ||
| EKVNELSTDIGSESTEDQAMEDIKEQLLR | ||
| STDIGSESTEDQAMEDIK | ||
| KKVEGFDMVQKPSYYVRLG | Perilipin 2 | MFG membrane[ |
| IHPFAQTQSLVYPFPGPIPKSLPQNIPPLTQTPVVVPPFLQPEIMGVSKVKEAMAPK | Casein beta | Casein micelle |
| VYPFPGPIPKSLPQNIPPLTQTPVVVPPFLQPEIMGVSKVKEAMAPK | ||
| RELEELNVPGEIVESLSSSEESITHIN | ||
| LYQEPVLGPVRGPFPIIV | ||
| VLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFP | ||
| EQEGEEIAEYRGR | Butyrophilin subfamily 1 member A1 | MFG membrane[ |
| FREKVSPAVFVSREGR | ||
| IPASLFPRLTPWM | ||
| SPAVFVSREGREQEGEEIAEYR | ||
| EEFPSMSESRNPDEEGLFTVR | ||
| NAVPITPTLNREQLSTSEENSKKTVDMESTEVITKKTK | Casein alpha S2 | Casein micelle |
| FPQYLQYLYQGPIVLNPWDQVKR | ||
| KTKLTEEDKNRLN | ||
| LNEINQFYQK | ||
| SSRQPQNQNPKLPLSILKEKHLRNAA | Glycosylation-dependent cell adhesion molecule 1 | MFG membrane[ |
| PQNQNPKLPLSILKEKHL | ||
| QPQNQNPKLPLSILKEKH | ||
| EQIVIRSSRQPQNQNPKLPLSILKEKHL | ||
| DTIAQAASTTTISDAVSKVKIQVNKAFLDSRT | Lactoperoxidase | Immune defense |
| DTIAQAASTTTISDAVSKVKIQVNKAFLDSRTRL | ||
| WPELENGQPTSEKYTVKADGEQSAKPEKAKETEKDDTGTPITKIEFVPSH | Sodium-dependent phosphate cotransporter 2B | MFG membrane[ |
| TPAQFDAEELR | Annexin A1 | MFG membrane[ |
| TPAQFDAEELRAAM | ||
| KTDLEKDIVSDTSGDFRK | Annexin A2 | MFG membrane[ |
| ELIDQDARDLYDAGVK | ||
| LSRYPSYGLNYYQQKPVALINNQFLPYPYYAKPAAVRSPAQIL | Casein kappa | Casein micelle |
| QEQNQEQPIR | ||
| EGVAINPARVLDLGPITR | pancreatic secretory granule membrane major glycoprotein GP2 | MFG membrane[ |
| NPARVLDLGPITR | ||
| KKPPQQLEWKLNTGRTEAW | Advanced glycosylation end-product specific receptor | Cell membrane |
| LAVRGEPGDSAAEEAAALTGEWR | Cyclin and CBS domain divalent metal cation transport mediator 3 | Cell membrane |
| EIAEAYETLSDANR | DnaJ Hsp family (Hsp40) member B9 | Vesicle membrane |
| FPALTEGYVGTLHENRQGSSVQAQIR | Protein tyrosine phosphatase receptor type G | Cell membrane |
| NPQGQSQITDPRQAQSSPPWSY | RUNX family transcription factor 2 | Nucleus |
| YNAPPEVVAAKMEVK | Secretoglobin family 1D member | Secreted |
| WSGPVGVSWGLR | Sortilin 1 | Vesicle membrane |
| NYLEDGESDGFLR | Transmembrane protein 59 | Vesicle membrane |
| VSTKGKRKPRQEEDEDYREFPQKKHKLYGRKQRPKAQPNPK | Zinc finger protein 512 | Nucleus |
*Peptides significantly more abundant in the sample group according to the Welch t test with FDR ≤ 0.01. MFG milk fat globule.
Figure 2Distribution of the differential peptides identified in NAS-positive (red) and healthy milk (blue) according to the cell location/function of the originating protein. The histograms display the number (A) and the abundance (B) of peptides in NAS-positive and healthy milk samples, respectively.
Figure 3Relative amino acid frequencies at the C-terminus. The figure illustrates the relative distribution of C-terminal amino acids in unique and significantly differential peptides found in NAS-positive (red) and healthy milk (blue), respectively.